Home / Conditions / Obesity
Obesity: when insurers say no, reviewers often say yes
In 1,389 published external-review decisions involving obesity, independent physician reviewers overturned the insurer’s denial 85.3% of the time.
Published decisions
1,389
2001–2026
Overturned
85.3%
1,185 denials reversed
Most-fought treatments for obesity
What insurers denied — and how those fights ended.
| Treatment | Decisions | Overturned |
|---|---|---|
| Wegovy | 486 | 90.7% |
| Zepbound | 439 | 94.8% |
| Wegovy Solution Auto-injector | 56 | 85.7% |
| Ozempic | 45 | 73.3% |
| Saxenda | 35 | 94.3% |
| Zepbound Solution Auto-injector | 35 | 94.3% |
| Mounjaro | 30 | 36.7% |
| Gastric Bypass Surgery | 21 | 52.4% |
| Tirzepatide | 12 | 91.7% |
| Bariatric Surgery | 12 | 41.7% |
How to use this in your appeal
These outcomes come from California’s external review program — an independent physician panel whose decision binds the insurer. Every state has an equivalent, and internal appeals succeed even more often. If your care for obesity was denied, the published record says the denial is worth fighting.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY
Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.